Honors College Senior Thesis Presentations

Title

The Use of Nebulizer Medications as an Effective Treatment for COVID-19

Presenter Information

Jacob KaufmanFollow

Academic Level at Time of Presentation

Senior

Major

Chemistry Pre-Pharmacy

Minor

Cell Biology

List all Project Mentors & Advisor(s)

Dr. Kevin Revell

Presentation Format

Oral Presentation

Abstract/Description

For the past few years, the COVID-19 pandemic has been the focal point in healthcare and research. Its effects have permanently changed daily life and left a historic impact on the world. Most people have felt the effects of this pandemic either directly, via infection, or indirectly, via change in work flow, financial impact, ect. The main question for this virus still remains today; how do we treat this illness effectively. While many ideas are being tested and suggested, a definite answer has yet to be procured. Vaccine rates are climbing on a daily basis, serving as the first and most beneficial form of prevention when it comes to spread and severity of infection. However, as new variants continue to mutate into existence, we are left wondering how long this virus will be an active threat. For this purpose, nebulizer medications may serve as an effective and long-term option to treat positive patient both in healthcare settings and at home. The main medications of ipratropium bromide and albuterol sulfate and their premixed combination have shown benefit in patients with other respiratory conditions such as COPD and Asthma. Given the correlation of symptoms between many of these diseases and COVID-19, there stands plausible support for the use of these medications for treatment of a viral COVID infection. If these medications were found to treat COVID symptoms, it would show that these medications hold stake as an efficient option. This would help to ease the strain on the healthcare system and bring peace of mind to those with growing concerns for their health and safety.

Spring Scholars Week 2022 Event

Honors College Senior Thesis Presentations

This document is currently not available here.

Share

COinS
 

The Use of Nebulizer Medications as an Effective Treatment for COVID-19

For the past few years, the COVID-19 pandemic has been the focal point in healthcare and research. Its effects have permanently changed daily life and left a historic impact on the world. Most people have felt the effects of this pandemic either directly, via infection, or indirectly, via change in work flow, financial impact, ect. The main question for this virus still remains today; how do we treat this illness effectively. While many ideas are being tested and suggested, a definite answer has yet to be procured. Vaccine rates are climbing on a daily basis, serving as the first and most beneficial form of prevention when it comes to spread and severity of infection. However, as new variants continue to mutate into existence, we are left wondering how long this virus will be an active threat. For this purpose, nebulizer medications may serve as an effective and long-term option to treat positive patient both in healthcare settings and at home. The main medications of ipratropium bromide and albuterol sulfate and their premixed combination have shown benefit in patients with other respiratory conditions such as COPD and Asthma. Given the correlation of symptoms between many of these diseases and COVID-19, there stands plausible support for the use of these medications for treatment of a viral COVID infection. If these medications were found to treat COVID symptoms, it would show that these medications hold stake as an efficient option. This would help to ease the strain on the healthcare system and bring peace of mind to those with growing concerns for their health and safety.